Abbott buys Bigfoot Biomedical to make diabetes management more precise & personal

American firms Abbott and Bigfoot Biomedical have announced a definitive agreement for Abbott to acquire&...

September 6, 2023 | Wednesday | News
STARLIMS acquires Labstep to expand portfolio across R&D through product commercialisation

US headquartered STARLIMS, a leading provider of enterprise informatics solutions, has announced the expansion of i...

August 22, 2023 | Tuesday | News
Sartorius and Repligen launch integrated system for upstream process intensification

German firm Sartorius and US-based Repligen Corporation have announced the launch of an integrated bioreactor ...

August 18, 2023 | Friday | News
Thermo Fisher unveils new line of refrigerators for storage of pharma products

US-based Thermo Fisher Scientific has announced a new line of Thermo Scientific TSG Series Refrigerators to ensure ...

August 9, 2023 | Wednesday | News
Waters unveils new size exclusion chromatography columns for gene therapy applications

US-based Waters Corporation has introduced the first in a new line of size exclusion chromatography (SEC) columns aimed ...

August 2, 2023 | Wednesday | News
Waters announces launch of new PeptideWorks Tryptic Protein Digestion

US-based Waters Corporation has launched its new PeptideWorks Tryptic Protein Digestion Kits to provide biopharma scient...

July 27, 2023 | Thursday | News
China-based Fapon announces global launch of Chemiluminescence Immunoassay system Shine i8000/9000

China headquartered life sciences company Fapon has announced the launch of its latest chemiluminescence immunoassa...

July 26, 2023 | Wednesday | News
Quest Diagnostics with Australian firm Envision Sciences launches novel prostate cancer test in US

US-based Quest Diagnostics has announced the launch of a novel prostate cancer biomarker test through its subspecialty p...

July 18, 2023 | Tuesday | News
Thermo Fisher introduces software to streamline routine diagnostics testing

To address challenges with error-prone, manual molecular testing workflows, US-based Thermo Fisher Scientific has introd...

July 13, 2023 | Thursday | News
US FDA approves Japanese pharma firm Eisai's treatment of Alzheimer’s Disease

Japan-headquartered Eisai Co. and US-based Biogen Inc. have announced that the US Food and Drug Administration...

July 10, 2023 | Monday | News
Hitachi collaborates with Mass General Brigham for R&D in regenerative medicine and GCT

Hitachi, Ltd. has entered a strategic framework collaboration agreement with the world-renowned medical research institu...

July 4, 2023 | Tuesday | News
Waters Corporation and Princeton University announce multi-year research collaboration

Waters Corporation has announced a multi-year research collaboration with Princeton University, in the US, that will ena...

July 3, 2023 | Monday | News
First South Asian microbiome company Leucine Rich Bio forays into US

Indian biotech firm Leucine Rich Bio, South Asia’s first microbiome company, is all set to foray into US healthcar...

June 21, 2023 | Wednesday | News
Illumina announces CEO transition plan, post battle with Carl Icahn

US-based Illumina Inc., a global leader in DNA sequencing and array-based technologies, has announced that its Board of ...

June 12, 2023 | Monday | News
Japan-based Fujifilm introduces first-of-its-kind human iPSC-derived blood-brain barrier isogenic kit

Fujifilm Cellular Dynamics, a leading global developer and manufacturer of human induced pluripotent stem cells (iPS...

June 5, 2023 | Monday | News
US FDA approves first oral anti-viral for treatment of COVID-19 in adults

The US Food and Drug Administration (FDA) has approved the oral anti-viral Paxlovid (nirmatrelvir tablets and ritonavir ...

May 26, 2023 | Friday | News
Sciex opens Echo MS Centre of Excellence in US

Sciex, a global leader in life science analytical technologies, recently celebrated the opening of the Echo MS Centre of...

May 24, 2023 | Wednesday | News
US investors back Australian innovation of retinal imaging with $12 M investment

New York-based healthtech company creation platform Ascertain is investing $12 (A$18) million in Eyetelligence, a ...

May 22, 2023 | Monday | News